Skip to content

Effects Magnesium Sulfate and Labetalol Infusion on Peripheral Perfusion and Pain in Nasal Surgeries

Effects of Magnesium Sulfate and Labetalol Infusion Used for Induced Hypotension on Peripheral Perfusion and Postoperative Pain in Nasal Surgeries

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04688203
Enrollment
50
Registered
2020-12-29
Start date
2021-02-01
Completion date
2021-09-30
Last updated
2022-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Perfusion, Postoperative Pain

Brief summary

One of main risk of controlled hypotension during nasal surgeries is impaired perfusion. Peripheral perfusion of non-vital organs usually impaired earlier than vital organs. So, evaluation of perfusion of non-vital organ is considered to be adequate measure of patient safety during surgery. Many hypotensive agents such as dexmedetomidine, B blockers, magnesium sulfate and nitroglycerine had been used but we are in need to investigate its effects on peripheral perfusion. Postoperative pain related to nasal surgeries due to surgical trauma itself which induces the release of inflammatory mediators from neuronal and immune cells resulting in peripheral and central sensitization significantly affects recovery of patients. Magnesium sulfate and labetalol have analgesic actions besides their hypotensive effects but with different mechanisms.

Detailed description

To compare between the effects of magnesium sulfate and labetalol infusion during induced hypotension on peripheral perfusion and postoperative pain in nasal surgeries OBJECTIVES: To measure peripheral perfusion index (PPI) as an indicator for peripheral perfusion To calculate the total postoperative rescue analgesic requirements. Double -blind randomized comparative Clinical Study. All Patients will be randomly allocated into two equal groups (group M and Group L). Using computer generated randomization table, each group will be 25 patients.

Interventions

will receive IV bolus dose of 40mg/kg magnesium sulfate in 100 ml saline solution over ten minutes then continuous infusion of 10-15mg/kg/h will be titrated till achieve target mean arterial blood pressure (55-65 mmHg) and will be terminated by the end of surgery.

DRUGLabetalol Injectable Solution

will receive IV bolus does of labetalol 0.25 mg/kg over ten minutes then continuous infusion of 0.5-1mg/kg/h will be titrated till achieve target mean arterial blood pressure (55-65 mmHg) and will be terminated by the end of surgery.

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Written informed consent from the patient. * Age: 21-45 years old. * Sex: both sex (males or females). * Physical status: ASA 1& II. * BMI = (20-30 kg/m2). * Type of operations: elective nasal surgeries such as septoplasty, endoscopic sinus surgery and polypectomy. * Duration of surgery ≤ two hours.

Exclusion criteria

* Altered mental state * Patients on beta blocker or with known history of allergy to study drugs. * Advanced hepatic, renal, cardiovascular or respiratory diseases. * Diabetic patients. * Patients receiving anticoagulants or on pain killers.

Design outcomes

Primary

MeasureTime frameDescription
Peripheral perfusion indexChanges from baseline Peripheral perfusion index at 2 hours.Peripheral perfusion index by pulse oximertry will be measured at basal, 3minutes after induction, every 10 minutes till end of surgery. It will be calculated by dividing the pulsatile signal to nonpulsatile. The normal range is (0.02% -20%)

Secondary

MeasureTime frameDescription
Heart ratebasal then at 3 minutes after intubation, and after skin incision then every 10 minutes till the end of surgeryHeart rate will be recorded at basal, 3 minutes after intubation, and after skin incision then every 10 min till the end of surgery.
postoperative Pain intensityat 30 minutes, 1 hour, 2hours, 4hours, 6hours, 12hours, and 24hours postoperative.Postoperative Pain will be assessed using Numerical rating Scale (NRS) . A commonly used scale is a 10-cm line labeled with worst pain imaginable on the right border and no pain on the left border. The patient will be instructed to make a mark along the line to represent the intensity of pain currently being experienced. NRS score 4 or more =pain. Paracetamol 1gm IV will be given every 6 hours as a protocol for pain management will be started at the end of surgery, and IV pethidine 1mg/kg (rescue analgesic) will be given if NRS \>4.
Mean arterial blood pressurebasal then at 3 minutes after intubation, and after skin incision then every 10 minutes till the end of surgeryMean arterial blood pressure will be recorded at basal, 3 minutes after intubation, and after skin incision then every 10 min till the end of surgery.
Total pethidine requirementsup to 24hour postoperativeTotal pethidine requirements
Serum lactate levelbasal and at one hour after extubationSerum lactate will be recorded basal and at one hour after extubation. The normal serum lactate ranges from 4.5 to 19.8 mg/dL
time to first call for pethidine (rescue analgesic)up to 24hour postoperativeTime from the stoppage of infusion solution to first call for pethidine (rescue analgesic) will be recorded.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026